Relmada Therapeutics Stock Forecast - Simple Moving Average
| RLMD Stock | USD 3.81 0.09 2.31% |
Relmada Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Relmada Therapeutics stock prices and determine the direction of Relmada Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Relmada Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The relative strength index (RSI) of Relmada Therapeutics' share price is at 50 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Relmada Therapeutics, making its price go up or down. Momentum 50
Impartial
Oversold | Overbought |
EPS Estimate Current Year (0.83) | EPS Estimate Next Year (0.36) | Wall Street Target Price 5.5 |
Using Relmada Therapeutics hype-based prediction, you can estimate the value of Relmada Therapeutics from the perspective of Relmada Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Relmada Therapeutics using Relmada Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Relmada using crowd psychology based on the activity and movement of Relmada Therapeutics' stock price.
Relmada Therapeutics Short Interest
A significant increase or decrease in Relmada Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Relmada. Short interest can provide insight into the potential direction of Relmada Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 1.0887 | Short Percent 0.013 | Short Ratio 0.62 | Shares Short Prior Month 980.7 K | 50 Day MA 2.6086 |
Relmada Relative Strength Index
The Simple Moving Average forecasted value of Relmada Therapeutics on the next trading day is expected to be 3.81 with a mean absolute deviation of 0.18 and the sum of the absolute errors of 10.40.Relmada Therapeutics Hype to Price Pattern
Investor biases related to Relmada Therapeutics' public news can be used to forecast risks associated with an investment in Relmada. The trend in average sentiment can be used to explain how an investor holding Relmada can time the market purely based on public headlines and social activities around Relmada Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Relmada Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Relmada Therapeutics.
Relmada Therapeutics Implied Volatility | 1.78 |
Relmada Therapeutics' implied volatility exposes the market's sentiment of Relmada Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Relmada Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Relmada Therapeutics stock will not fluctuate a lot when Relmada Therapeutics' options are near their expiration.
The Simple Moving Average forecasted value of Relmada Therapeutics on the next trading day is expected to be 3.81 with a mean absolute deviation of 0.18 and the sum of the absolute errors of 10.40. Relmada Therapeutics after-hype prediction price | USD 3.82 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Relmada Therapeutics to cross-verify your projections. Open Interest Against 2026-03-20 Relmada Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Relmada Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Relmada Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Relmada Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Relmada Therapeutics' open interest, investors have to compare it to Relmada Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Relmada Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Relmada. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Relmada Therapeutics Additional Predictive Modules
Most predictive techniques to examine Relmada price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Relmada using various technical indicators. When you analyze Relmada charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Relmada Therapeutics Simple Moving Average Price Forecast For the 27th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Relmada Therapeutics on the next trading day is expected to be 3.81 with a mean absolute deviation of 0.18, mean absolute percentage error of 0.05, and the sum of the absolute errors of 10.40.Please note that although there have been many attempts to predict Relmada Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Relmada Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Relmada Therapeutics Stock Forecast Pattern
| Backtest Relmada Therapeutics | Relmada Therapeutics Price Prediction | Buy or Sell Advice |
Relmada Therapeutics Forecasted Value
In the context of forecasting Relmada Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Relmada Therapeutics' downside and upside margins for the forecasting period are 0.04 and 9.96, respectively. We have considered Relmada Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Relmada Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Relmada Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.505 |
| Bias | Arithmetic mean of the errors | -0.0368 |
| MAD | Mean absolute deviation | 0.1763 |
| MAPE | Mean absolute percentage error | 0.0455 |
| SAE | Sum of the absolute errors | 10.4 |
Predictive Modules for Relmada Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Relmada Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Relmada Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Relmada Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Relmada Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Relmada Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Relmada Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Relmada Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Relmada Therapeutics' historical news coverage. Relmada Therapeutics' after-hype downside and upside margins for the prediction period are 0.19 and 9.97, respectively. We have considered Relmada Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Relmada Therapeutics is risky at this time. Analysis and calculation of next after-hype price of Relmada Therapeutics is based on 3 months time horizon.
Relmada Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Relmada Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Relmada Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Relmada Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.89 | 6.15 | 0.01 | 0.03 | 9 Events / Month | 6 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.81 | 3.82 | 0.26 |
|
Relmada Therapeutics Hype Timeline
Relmada Therapeutics is at this time traded for 3.81. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.03. Relmada is expected to increase in value after the next headline, with the price projected to jump to 3.82 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.26%, whereas the daily expected return is at this time at 0.89%. The volatility of related hype on Relmada Therapeutics is about 19218.75%, with the expected price after the next announcement by competition of 3.78. Net Loss for the year was (79.98 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next expected press release will be in about 9 days. Check out Historical Fundamental Analysis of Relmada Therapeutics to cross-verify your projections.Relmada Therapeutics Related Hype Analysis
Having access to credible news sources related to Relmada Therapeutics' direct competition is more important than ever and may enhance your ability to predict Relmada Therapeutics' future price movements. Getting to know how Relmada Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Relmada Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ACRV | Acrivon Therapeutics Common | (0.36) | 6 per month | 7.75 | 0.04 | 8.21 | (9.09) | 66.02 | |
| PMVP | Pmv Pharmaceuticals | (0.04) | 8 per month | 0.00 | (0.12) | 5.98 | (4.58) | 13.80 | |
| IMUX | Immunic | (0.05) | 7 per month | 0.00 | (0.06) | 9.43 | (6.58) | 17.09 | |
| TCRX | Tscan Therapeutics | (0.03) | 9 per month | 0.00 | (0.15) | 9.62 | (9.68) | 40.38 | |
| VXRT | Vaxart Inc | 0.02 | 10 per month | 5.89 | 0.14 | 15.15 | (5.41) | 75.42 | |
| LITS | Lite Strategy | (0.05) | 6 per month | 0.00 | (0.10) | 7.73 | (9.52) | 26.34 | |
| FBIO | Fortress Biotech | 0.18 | 12 per month | 4.09 | 0.08 | 6.63 | (6.45) | 29.21 | |
| RPTX | Repare Therapeutics | 0.06 | 11 per month | 1.48 | 0.11 | 3.95 | (3.26) | 35.71 | |
| CBUS | Cibus Global LLC | (0.07) | 5 per month | 6.03 | 0.01 | 11.03 | (9.37) | 33.18 | |
| ACET | Adicet Bio | 0.02 | 34 per month | 0.00 | (0.21) | 6.18 | (7.60) | 16.66 |
Other Forecasting Options for Relmada Therapeutics
For every potential investor in Relmada, whether a beginner or expert, Relmada Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Relmada Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Relmada. Basic forecasting techniques help filter out the noise by identifying Relmada Therapeutics' price trends.Relmada Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Relmada Therapeutics stock to make a market-neutral strategy. Peer analysis of Relmada Therapeutics could also be used in its relative valuation, which is a method of valuing Relmada Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Relmada Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Relmada Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Relmada Therapeutics shares will generate the highest return on investment. By undertsting and applying Relmada Therapeutics stock market strength indicators, traders can identify Relmada Therapeutics entry and exit signals to maximize returns.
Relmada Therapeutics Risk Indicators
The analysis of Relmada Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Relmada Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting relmada stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.52 | |||
| Semi Deviation | 3.91 | |||
| Standard Deviation | 6.19 | |||
| Variance | 38.26 | |||
| Downside Variance | 19.36 | |||
| Semi Variance | 15.3 | |||
| Expected Short fall | (5.94) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Relmada Therapeutics
The number of cover stories for Relmada Therapeutics depends on current market conditions and Relmada Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Relmada Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Relmada Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Relmada Therapeutics Short Properties
Relmada Therapeutics' future price predictability will typically decrease when Relmada Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Relmada Therapeutics often depends not only on the future outlook of the potential Relmada Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Relmada Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.2 M | |
| Cash And Short Term Investments | 44.9 M |
Check out Historical Fundamental Analysis of Relmada Therapeutics to cross-verify your projections. For information on how to trade Relmada Stock refer to our How to Trade Relmada Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Relmada Therapeutics. If investors know Relmada will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Relmada Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Relmada Therapeutics is measured differently than its book value, which is the value of Relmada that is recorded on the company's balance sheet. Investors also form their own opinion of Relmada Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Relmada Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Relmada Therapeutics' market value can be influenced by many factors that don't directly affect Relmada Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Relmada Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Relmada Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Relmada Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.